All In Biotech

Drug Trial Radar · NCT02835404

Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical Cancer

A Randomized, Open Label, Single Centre Clinical Trial of Pelvic External Radiotherapy Combined With 252-Cf Neutron Intracavitary Brachytherapy With or Without Platinum in Treatment of Local Advanced Cervical Cancer

Last checked: Nov 19, 2026Latest source record: Jul 18, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

200

Planned (sponsor's estimate)

Start

Nov 2012

Primary completion

Jun 2017

Study completion Nov 2018

Sponsor

Sponsor type
Academic, hospital or other
First posted
Jul 18, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study was to evaluate the efficacy and complication of the treatment of pelvic external combined with 252-Cf neutron intracavitary radiotherapy with or without platinum in local advanced cervical cancer patients in the short and long term.

Conditions

  • Cervical Cancer
  • Complications

Interventions

  • NedaplatinDrug

    Chemotherapy: Nedaplatin(NDP) 30-40mg/m2 iv., on day1, 4weeks as one cycle

  • Pelvic External RadiotherapyRadiation

    patients received 20 Gy2.0/f, for 25-27f (SSD)with 8mv-X rays (SSD)

  • 252-Cf Neutron Intracavitary BrachytherapyRadiation

    total dose of reference point A was 4400cGy, in four times Transvaginal implant sessions during Pelvic External Radiations

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Acute toxicity eventsTime frame: Week 5 of Radiation Therapy (RT)
  2. Long-trem toxicity eventsTime frame: through study completion, an average of 5 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

    Chongqing, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.